Gus Khursigara

Nessuna posizione attualmente

Consumer Services

Health Technology

Commercial Services

Profilo

Gus Khursigara worked as Vice President-Global Medical Affairs at Alexion Pharmaceuticals, Inc. and as VP-Medical Affairs & Clinical Operations at Inozyme Pharma, Inc. He also worked as Vice President-Global Medical Affairs at Biohaven Pharmaceuticals, Inc. from 2018 to 2019.
Mr. Khursigara holds a doctorate degree from Cornell University, an undergraduate degree from the University of California San Diego, and a graduate degree from the University of Connecticut.

Precedenti posizioni note di Gus Khursigara

Società	Posizione	Fine
Biohaven Pharmaceuticals, Inc. Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT.	Direttore Tecnico/Scientifico/R&S	01/09/2019
ALEXION PHARMACEUTICALS, INC.	Direttore Tecnico/Scientifico/R&S	-
INOZYME PHARMA, INC.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Gus Khursigara

Formazione di Gus Khursigara

Cornell University	Doctorate Degree
University of Connecticut	Graduate Degree
University of California San Diego	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Gus Khursigara

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
INOZYME PHARMA, INC.	Health Technology

Aziende private	2
Biohaven Pharmaceuticals, Inc. Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT.	Commercial Services
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.	Health Technology